An integrative structural biology approach to the study of T cell signaling -Equipment Supplement
研究 T 细胞信号转导的综合结构生物学方法 - 设备补充
基本信息
- 批准号:10260718
- 负责人:
- 金额:$ 23.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigen-Presenting CellsAntigensBasic ScienceCD3 AntigensCell membraneCell surfaceCellsClinicalComplexComputer ModelsCryoelectron MicroscopyCustomData SetEngineeringEquipmentGoalsHybridsImmuneImmunologic Deficiency SyndromesImmunotherapyKnowledgeMajor Histocompatibility ComplexMembrane ProteinsMethodologyMethodsMindMolecularMolecular ConformationPathway interactionsPeptidesProcessPropertyReceptor ActivationResearchSignal TransductionSpecificityStructureT-Cell ReceptorT-LymphocyteViral CancerVirusVirus Diseasesadaptive immunitycombatcytotoxic CD8 T cellsimmune functioninnovationinsightnew technologynovelprogramsprotein complexreceptorreceptor functionstructural biologythree dimensional structuretooltumor
项目摘要
Summary
I propose to develop and apply innovative hybrid structural biology tools to investigate the
molecular mechanism of signaling through the T cell receptor (TCR) complex. This is a
fundamental adaptive immunity pathway through which cytotoxic CD8+ T cells can detect the
presence of viruses and developing tumors in the body. Immune function is achieved through
the continuous surveillance of antigen-presenting cells for short peptides displayed within the
molecules of the Major Histocompatibility Complex (MHC) on the cell surface. Key to the initiation
of signaling, is a multi-subunit membrane protein assembly consisting of a clonotypic TCR
heterodimer that recognizes the peptide-MHC, together with the invariant CD3 co-receptor
hexamer that relays an activation signal from the cell surface intracellularly, through the plasma
membrane. Besides the fundamental basic science merit, characterizing this process at atomic
detail has important clinical implications, as is suggested by the large number of
immunodeficiencies resulting from dysregulation of the signaling components and their
interactions.
Despite a large number of functional and structural studies, elucidating the 3D structure of the
signaling complex as a whole remains extremely challenging by conventional methods, due to
its size and dynamic complexity. As a result, the interactions between the TCR and CD3 subunits
and the crucial conformational changes needed for signaling remain incompletely characterized.
With these bottlenecks in mind, I have developed a new methodology combining datasets from
complementary approaches, such as NMR, SANS and cryoEM, together with computational
modeling using the program Rosetta to solve the structures of such challenging complexes.
Here, I propose to apply this powerful integrative approach to elucidate the T cell receptor
complex structure, and to study its dynamic transitions between inactive and active
conformations. My immediate goal is to determine the molecular basis of TCR/CD3 interactions
and to characterize the crucial structural changes in receptor complex arrangement upon antigen
recognition. As a long-term goal, I plan to use a structure-guided approach to engineer novel T
cell receptors with custom specificities and signaling properties, to be used in emerging
immunotherapy applications.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nikolaos Sgourakis其他文献
Nikolaos Sgourakis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nikolaos Sgourakis', 18)}}的其他基金
Molecular mechanism of antigen editing by Class-I MHC Chaperones
I类MHC伴侣编辑抗原的分子机制
- 批准号:
10319575 - 财政年份:2019
- 资助金额:
$ 23.49万 - 项目类别:
Molecular mechanism of antigen editing by Class-I MHC Chaperones
I类MHC伴侣编辑抗原的分子机制
- 批准号:
10531131 - 财政年份:2019
- 资助金额:
$ 23.49万 - 项目类别:
Molecular mechanism of antigen editing by Class-I MHC Chaperones
I类MHC伴侣编辑抗原的分子机制
- 批准号:
10201060 - 财政年份:2019
- 资助金额:
$ 23.49万 - 项目类别:
Molecular mechanism of antigen editing by Class-I MHC Chaperones
I类MHC伴侣编辑抗原的分子机制
- 批准号:
10078937 - 财政年份:2019
- 资助金额:
$ 23.49万 - 项目类别:
An integrative structural biology approach to the study of T cell signaling
研究 T 细胞信号传导的综合结构生物学方法
- 批准号:
10191789 - 财政年份:2017
- 资助金额:
$ 23.49万 - 项目类别:
An integrative structural biology approach to the study of T cell signaling
研究 T 细胞信号传导的综合结构生物学方法
- 批准号:
10242813 - 财政年份:2017
- 资助金额:
$ 23.49万 - 项目类别:
A structural approach to the study of viral Immune interference mechanisms
研究病毒免疫干扰机制的结构方法
- 批准号:
9069732 - 财政年份:2015
- 资助金额:
$ 23.49万 - 项目类别:
相似海外基金
Tri-Signal Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的三信号人工抗原呈递细胞
- 批准号:
10751133 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的微流控精密工程人工抗原呈递细胞
- 批准号:
10696138 - 财政年份:2022
- 资助金额:
$ 23.49万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10663066 - 财政年份:2022
- 资助金额:
$ 23.49万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10537159 - 财政年份:2022
- 资助金额:
$ 23.49万 - 项目类别:
Analysis of the function of antigen-presenting cells present in the stroma of colorectal cancer and the intracellular microbiome
结直肠癌基质中抗原呈递细胞和细胞内微生物组的功能分析
- 批准号:
21K08723 - 财政年份:2021
- 资助金额:
$ 23.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
- 批准号:
10156950 - 财政年份:2021
- 资助金额:
$ 23.49万 - 项目类别:
The role of CX3CR1+ antigen presenting cells in T cell selection and central tolerance"
CX3CR1抗原呈递细胞在T细胞选择和中枢耐受中的作用"
- 批准号:
10631854 - 财政年份:2021
- 资助金额:
$ 23.49万 - 项目类别:
Reprogramming Cancer Cells into Antigen Presenting Cells: Cancer Vaccination with mRNA Enabled by Charge-Altering Releasable Transporters
将癌细胞重编程为抗原呈递细胞:通过改变电荷的可释放转运蛋白实现 mRNA 的癌症疫苗接种
- 批准号:
10153927 - 财政年份:2021
- 资助金额:
$ 23.49万 - 项目类别:
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
- 批准号:
10331830 - 财政年份:2021
- 资助金额:
$ 23.49万 - 项目类别:
Analysis on detrimental interplay between pathogenic helper T cells, inflammatory antigen-presenting cells and disease-associated microglia in chronic pathogenesis of multiple sclerosis
多发性硬化症慢性发病机制中致病性辅助 T 细胞、炎症抗原呈递细胞和疾病相关小胶质细胞之间的有害相互作用分析
- 批准号:
20K16294 - 财政年份:2020
- 资助金额:
$ 23.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists